Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
出版年份 2022 全文链接
标题
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
作者
关键词
TB, MDR-TB, delamanid, bedaquiline, effectiveness, safety
出版物
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-03-02
DOI
10.1016/j.ijid.2022.02.043
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects
- (2021) D. Visca et al. Pulmonology
- QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial
- (2021) Kelly E Dooley et al. LANCET INFECTIOUS DISEASES
- New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization
- (2021) Kerri Viney et al. EUROPEAN RESPIRATORY JOURNAL
- Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
- (2021) S. Koirala et al. Pulmonology
- Treatment success using novel and adapted treatment regimens in registered DR-TB children in Dushanbe, Tajikistan, 2013-2019
- (2021) Bobojon Pirmahmadzoda et al. Journal of Infection in Developing Countries
- MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
- (2020) Giovanni Battista Migliori et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Bedaquiline and Delamanid in Children With XDR Tuberculosis
- (2020) Ira Shah et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
- (2020) Marina Tadolini et al. EUROPEAN RESPIRATORY JOURNAL
- Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid
- (2020) Suha Kadura et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts
- (2020) I. Motta et al. Pulmonology
- Delamanid resistance: update and clinical management
- (2020) Thi Van Anh Nguyen et al. CLINICAL INFECTIOUS DISEASES
- Long-term safety and tolerability of delamanid-containing regimens in MDR- and XDR-TB patients in a specialised tuberculosis treatment center in Berlin, Germany
- (2020) Brit Häcker et al. EUROPEAN RESPIRATORY JOURNAL
- Correspondence regarding “Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa”
- (2020) Erika Mohr-Holland et al. EUROPEAN RESPIRATORY JOURNAL
- Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea
- (2020) Hyungseok Kang et al. RESPIRATORY MEDICINE
- Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multi-Drug Resistant Tuberculosis
- (2020) Xiaofeng Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- One step forward: Successful end-of-treatment outcomes of drug-resistant TB patients who received concomitant bedaquiline and delamanid in Mumbai, India
- (2020) Mrinalini Das et al. CLINICAL INFECTIOUS DISEASES
- Concurrent Use of Bedaquiline and Delamanid for the Treatment of Fluoroquinolone-resistant Multidrug-resistant Tuberculosis: A Nationwide Cohort Study in South Korea
- (2020) Yong-Soo Kwon et al. EUROPEAN RESPIRATORY JOURNAL
- Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid
- (2020) Hoon Hee Lee et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Compassionate Use of Delamanid in Adults and Children for Drug-resistant TB: 5-year Update
- (2020) Sambuddha Ghosh et al. EUROPEAN RESPIRATORY JOURNAL
- New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India
- (2020) M. Das et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial
- (2019) Florian von Groote-Bidlingmaier et al. Lancet Respiratory Medicine
- Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea
- (2019) Jeongha Mok et al. EUROPEAN RESPIRATORY JOURNAL
- Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
- (2019) Payam Nahid et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug resistant tuberculosis
- (2019) Olatunde Olayanju et al. EUROPEAN RESPIRATORY JOURNAL
- Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
- (2019) Sergey Borisov et al. EUROPEAN RESPIRATORY JOURNAL
- Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea
- (2018) Cheon Tae Kim et al. EUROPEAN RESPIRATORY JOURNAL
- Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa
- (2018) Erika Mohr et al. EUROPEAN RESPIRATORY JOURNAL
- Early experience with delamanid-containing regimens in the treatment of complicated multidrug-resistant tuberculosis in Hong Kong
- (2018) Kwok-Chiu Chang et al. EUROPEAN RESPIRATORY JOURNAL
- Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review
- (2018) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study
- (2018) Gabriella Ferlazzo et al. LANCET INFECTIOUS DISEASES
- Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
- (2018) Elizabeth P. Harausz et al. PLOS MEDICINE
- Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
- (2018) Nafees Ahmad et al. LANCET
- Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis
- (2018) Jeffrey Hafkin et al. EUROPEAN RESPIRATORY JOURNAL
- Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
- (2017) Sergey E. Borisov et al. EUROPEAN RESPIRATORY JOURNAL
- Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens
- (2017) Liga Kuksa et al. EUROPEAN RESPIRATORY JOURNAL
- Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
- (2017) Jeffrey Hafkin et al. EUROPEAN RESPIRATORY JOURNAL
- Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
- (2017) Giovanni Migliori et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review
- (2017) Lia D’Ambrosio et al. Journal of Thoracic Disease
- Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
- (2016) Marina Tadolini et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid: TABLE 1
- (2015) Charles D. Wells et al. EUROPEAN RESPIRATORY JOURNAL
- ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use
- (2014) S. Esposito et al. EUROPEAN RESPIRATORY JOURNAL
- Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
- (2012) Vija Skripconoka et al. EUROPEAN RESPIRATORY JOURNAL
- Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
- (2012) Maria Tarcela Gler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
- (2011) A. H. Diacon et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started